A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.

Warren, Katherine E

A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study. [electronic resource] - Journal of neuro-oncology Feb 2012 - 643-9 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural

1573-7373

10.1007/s11060-011-0709-z doi


Adolescent
Antineoplastic Agents--therapeutic use
Brain Stem Neoplasms--drug therapy
Child
Child, Preschool
DNA Modification Methylases--metabolism
DNA Repair Enzymes--metabolism
Dacarbazine--analogs & derivatives
Drug Therapy, Combination--methods
Female
Glioma--drug therapy
Guanine--analogs & derivatives
Humans
Kaplan-Meier Estimate
Ki-67 Antigen--metabolism
Male
Proportional Hazards Models
Retrospective Studies
Temozolomide
Tumor Suppressor Proteins--metabolism
Young Adult